Hyperbilirubinemia in hospitalized patients: Etiology and outcomes

医学 内科学 黄疸 病因学 队列 胆红素 胃肠病学 恶性肿瘤 肝病 回顾性队列研究 原发性胆汁性肝硬化 贫血 儿科
作者
Joshua Kwon,Paul J. Nietert,Don C. Rockey
出处
期刊:Journal of Investigative Medicine [SAGE Publishing]
卷期号:71 (7): 773-781
标识
DOI:10.1177/10815589231180498
摘要

There is little information on the differential diagnosis and prognosis of hospitalized patients with hyperbilirubinemia. Here, we hypothesized that hyperbilirubinemia in hospitalized patients is associated with specific diseases and outcomes. This retrospective cohort analysis included patients admitted to the Medical University of South Carolina with a total bilirubin >3 mg/dL from January 9, 2015 to August 25, 2017. Collected clinical data included demographics, primary diagnosis, Charlson Comorbidity Index (CCI), laboratory data, and clinical outcomes. We separated and analyzed the cohort into seven primary diagnostic groups. We identified 1693 patients with a bilirubin level >3 mg/dL. The cohort was 42% female, had an average age of 54, average CCI of 4.8, and average length of stay of 13 days. The causes of hyperbilirubinemia included the following: primary liver disease (868/1693; 51%) with cirrhosis being most common (385/1693; 23%), benign biliary obstruction (252/1693; 15%), hemolytic anemia (149/1693; 9%), malignant biliary obstruction (121/1693; 7%), unknown etiology (108/1693; 6%), primary liver cancer (74/1693; 4%), and metastatic cancer to the liver (57/1693; 3%). Overall, the mortality/discharge to hospice rate in patients with a bilirubin >3 mg/dL was 30%, and was proportional to the severity of hyperbilirubinemia, including when controlling for the underlying severity of illness. Mortality was highest in patients with primary liver disease and malignancy and was lowest in patients with non-cancerous obstruction or hemolytic jaundice. Hyperbilirubinemia in hospitalized patients is most often due to primary liver disease, and identifies patients with a poor prognosis, particularly when caused by primary liver disease or cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
maitiandehe发布了新的文献求助10
刚刚
鱼儿吐泡泡完成签到,获得积分10
2秒前
甲壳虫完成签到 ,获得积分10
2秒前
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
NexusExplorer应助科研通管家采纳,获得10
3秒前
科研通AI5应助科研通管家采纳,获得10
3秒前
大个应助科研通管家采纳,获得10
4秒前
qikkk应助科研通管家采纳,获得10
4秒前
4秒前
Piper关注了科研通微信公众号
4秒前
4秒前
4秒前
脑洞疼应助科研通管家采纳,获得10
4秒前
5秒前
科研猫完成签到,获得积分10
6秒前
6秒前
今后应助遥远采纳,获得30
6秒前
激昂的逊发布了新的文献求助10
7秒前
李爱国应助ixueyi采纳,获得10
7秒前
秀丽誉完成签到,获得积分10
8秒前
8秒前
9秒前
10秒前
hanatae完成签到,获得积分10
10秒前
WDD完成签到,获得积分10
11秒前
张慧完成签到,获得积分10
12秒前
秀丽誉发布了新的文献求助10
12秒前
可爱的函函应助Elody采纳,获得30
13秒前
15秒前
紫紫吃菠菜完成签到,获得积分10
16秒前
雪梅发布了新的文献求助10
17秒前
激昂的逊完成签到,获得积分10
17秒前
Piper发布了新的文献求助10
18秒前
19秒前
科研通AI2S应助英勇的曲奇采纳,获得10
20秒前
20秒前
20秒前
12Q发布了新的文献求助10
21秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976418
求助须知:如何正确求助?哪些是违规求助? 3520512
关于积分的说明 11203586
捐赠科研通 3257127
什么是DOI,文献DOI怎么找? 1798594
邀请新用户注册赠送积分活动 877804
科研通“疑难数据库(出版商)”最低求助积分说明 806523